Mapping large numbers of results may take a few moments.
Search Results
Showing 151 - 200 of 396 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Essential Pharmaceuticals LLC | Activity: Research and Development | Company Description Essential Pharmaceuticals sells organ preservation solutions. | Location Durham | |
Company EternaTear Inc. | Activity: Research and Development | Company Description EternaTear had developed a novel artificial tear formulation that provides long lasting ocular lubrication to offer relief from dry eye. | Location Raleigh | |
Company Evecxia Inc. | Activity: Research and Development | Company Description Evecxia is developing drugs which amplify serotonin synthesis to treat neuropsychiatric conditions for which current therapies are inadequate. | Location Research Triangle Park | |
Company Extrel Therapeutics Inc. | Activity: Research and Development | Company Description Extrel Therapeutics is developing medical devices to protect patients from post-operative infection, pain and inflammation. | Location Raleigh | |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham | |
Company Eyedesis Biosciences LLC | Activity: Research and Development | Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. | Location Chapel Hill | |
Company FafaBiotic LLC | Activity: Research and Development | Company Description Fafabiotic develops bioformulations for topical and ingestible probiotics for human health. Fafabiotic also offers consulting services on various aspects of biological product development, from feasibility and technology evaluation to scale-up and readiness for commercialization. | Location Cary | |
Company FastBack Bio LLC | Activity: Research and Development | Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. | Location Raleigh | |
Company Fennec Pharmaceuticals Inc. | Activity: Research and Development | Company Description Fennec Pharmaceuticals develops a sodium thiosulfate formula for the prevention of ototoxicity from cisplatin in pediatric patients. | Location Research Triangle Park | |
Company Fernel Therapeutics Inc. | Activity: Research and Development | Company Description Fernel Therapeutics develops medical devices and pharmaceuticals for the treatment of benign or non-infectious diseases of the pelvic region. | Location Apex | |
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh | |
Company Focal Medical Inc. | Activity: Research and Development | Company Description Focal Medical develops novel therapeutic products based on its local drug delivery technology platform. | Location Cary | |
Company Foundation Medicine Inc. | Activity: Research and Development | Company Description Foundation Medicine develops and provides clinical assays that provide a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials. | Location Morrisville | |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park | |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham | |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park | |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park | |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham | |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill | |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh | |
Company Genoverde Biosciences Inc. | Activity: Research and Development | Company Description Genoverde Biosciences is developing improved varieties of industrial hemp through traditional breeding and genetic engineering technologies for agricultural and biomedical applications. | Location Raleigh | |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill | |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill | |
Company Gradient Medical Inc. | Activity: Research and Development | Company Description Gradient Medical develops interventional oncology therapies to treat primary and metastatic tumors using minimally invasive nanosecond pulsed electric fields. | Location Cary | |
Company GreenLight Biosciences Inc. | Activity: Research and Development | Company Description Greenlight Biosciences has developed a cell-free bioprocessing method for the low-cost production of RNA for use in research in vaccine development, vector control, pandemic preparation, crop management and crop pesticides. | Location Research Triangle Park | |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham | |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham | |
Company Gusto Global LLC | Activity: Research and Development | Company Description Gusto Global is developing a discovery platform that integrates advanced computational and lab-based discovery tools to develop next-generation microbiome-based therapeutics & diagnostics. | Location Research Triangle Park | |
Company Hedros Biotechnology | Activity: Research and Development | Company Description Hedros Biotechnology has developed a software platform to create custom bacteriophage cocktails, with the goal to eradicate acute hepatopancreatic necrosis disease (AHPND) in shrimp. | Location Raleigh | |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh | |
Company HemoSonics LLC | Activity: Research and Development | Company Description HemoSonics is developing an in vitro diagnostic platform that measures the evolving stiffness of forming blood clots within a consumable test cartridge. Its technology assists with the management of coagulation dysfunctions at the point of care. | Location Durham | |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh | |
Company Hoofprint Biome | Activity: Research and Development | Company Description Hoofprint Biome engineers probiotics to eliminate methane from livestock while improving production performance. | Location Raleigh | |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park | |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham | |
Company Iluma Alliance | Activity: Research and Development | Company Description Iluma Alliance develops, manufactures and markets nutritional and health ingredients for animals, as well as nutritional ingredients for humans. This location is the innovation labs and conducts research on feed additives for animal nutrition and health. | Location Durham | |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh | |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham | |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park | |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham | |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill | |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh | |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park | |
Company Indigo Agriculture | Activity: Research and Development | Company Description Indigo Agriculture utilizes plant microbes to improve crop health and productivity, with a portfolio focused on cotton, wheat, corn, soybeans and rice. | Location Research Triangle Park | |
Company IngateyGen LLC | Activity: Research and Development | Company Description IngateyGen is an early stage Ag Biotech company using CRISPR genome editing technology to develop an allergen reduced peanut, a peanut with modified oil profile and an ultra high protein peanut for improved safety and nutritional value to consumers. | Location Research Triangle Park | |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville | |
Company Inivata Inc. | Activity: Research and Development | Company Description Inivata develops a noninvasive liquid biopsy diagnostic using the precision of circulating tumor DNA (ctDNA) analysis for improving cancer detection and assessing individual response to treatment. | Location Research Triangle Park | |
Company Innatrix Inc. | Activity: Research and Development | Company Description Innatrix is developing eco-friendly alternative means of crop protection, utilizing a patented peptide & RNAi delivery technology platform. | Location Research Triangle Park | |
Company Innovasive Environmental LLC | Activity: Research and Development | Company Description Innovasive Environmental develops environmentally-friendly, species-specific herbicides based on a species’ genome. | Location Black Mountain | |
Company Innovative Neurophysiology Inc. | Activity: Research and Development | Company Description Innovative Neurophysiology designs and develops advanced tools, equipment and methodology for neuroscience research. | Location Durham |